Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

INTRODUCTION: Various pharmacological treatments are available for preterm infants with patent ductus arteriosus (PDA), but their risks and benefits are controversial. This study aimed to identify the best treatment for PDA using network meta-analysis (NMA) and risk-benefit assessment (RBA). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Eursiriwan, Sudarat, Okascharoen, Chusak, Vallibhakara, Sakda Arj-Ong, Pattanaprateep, Oraluck, Numthavaj, Pawin, Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710462/
https://www.ncbi.nlm.nih.gov/pubmed/36465804
http://dx.doi.org/10.1159/000526318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710462/
https://www.ncbi.nlm.nih.gov/pubmed/36465804
http://dx.doi.org/10.1159/000526318

Ejemplares similares